Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$45.1M |
| 2 |
Cisco
CSCO
|
+$38.8M |
| 3 |
Oracle
ORCL
|
+$37M |
| 4 |
DuPont de Nemours
DD
|
+$36.5M |
| 5 |
Eli Lilly
LLY
|
+$30.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$61.2M |
| 2 |
Wells Fargo
WFC
|
+$52.2M |
| 3 |
Amazon
AMZN
|
+$49.5M |
| 4 |
Chemours
CC
|
+$49.3M |
| 5 |
Pfizer
PFE
|
+$44.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.09% |
| 2 | Industrials | 17.32% |
| 3 | Healthcare | 15.49% |
| 4 | Consumer Discretionary | 13.3% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Boyd Gaming
BYD
$5.87B
| $350K | 0.01% |
12,984
-817
| -6% | -$22.3K |
|
|
INOV
902
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $350K | 0.01% |
24,115
-185
| -0.8% | -$2.51K |
|
903
Molina Healthcare
MOH
$10.5B
| $349K | 0.01% |
2,435
-3,056
| -56% | -$419K |
|
904
Applied Industrial Technologies
AIT
$12.5B
| $348K | 0.01% |
5,661
-13,071
| -70% | -$764K |
|
905
Air Products & Chemicals
APD
$67.9B
| $347K | 0.01% |
1,533
-8,359
| -85% | -$1.73M |
|
906
Boston Beer
SAM
$1.91B
| $346K | 0.01% |
917
-2,109
| -70% | -$668K |
|
907
Axcelis
ACLS
$3.92B
| $344K | 0.01% |
22,840
-21,394
| -48% | -$382K |
|
|
TBCH
908
Turtle Beach Corp
TBCH
$227M
| $344K | 0.01% |
+29,785
| New | +$315K |
|
909
TechnipFMC
FTI
$30.4B
| $340K | 0.01% |
17,637
-9,974
| -36% | -$175K |
|
910
Madison Square Garden
MSGS
$9.78B
| $340K | 0.01% |
+1,702
| New | +$362K |
|
911
STAAR Surgical
STAA
$1.16B
| $339K | 0.01% |
11,548
-8,560
| -43% | -$247K |
|
912
Axalta
AXTA
$7.75B
| $338K | 0.01% |
11,338
-387,873
| -97% | -$10.3M |
|
913
e.l.f. Beauty
ELF
$6.02B
| $338K | 0.01% |
23,987
-10,297
| -30% | -$125K |
|
914
Global Industrial
GIC
$1.5B
| $338K | 0.01% |
15,249
-13,893
| -48% | -$304K |
|
915
Exelon
EXC
$45.1B
| $337K | 0.01% |
9,870
-266,761
| -96% | -$9.42M |
|
|
SMAR
916
DELISTED
Smartsheet Inc.
SMAR
| $337K | 0.01% |
+6,953
| New | +$295K |
|
|
S
917
DELISTED
Sprint Corporation
S
| $337K | 0.01% |
51,305
-20,231
| -28% | -$128K |
|
|
VSTO
918
DELISTED
Vista Outdoor Inc.
VSTO
| $337K | 0.01% |
+37,996
| New | +$326K |
|
919
Akamai
AKAM
$15.9B
| $335K | 0.01% |
4,176
-6,197
| -60% | -$479K |
|
920
GSK
GSK
$105B
| $335K | 0.01% |
6,704
| – | – |
|
921
Pricesmart
PSMT
$5.33B
| $335K | 0.01% |
+6,550
| New | +$365K |
|
922
MasTec
MTZ
$21.4B
| $331K | 0.01% |
6,420
-2,156
| -25% | -$107K |
|
923
Vertex Pharmaceuticals
VRTX
$139B
| $330K | 0.01% |
+1,801
| New | +$315K |
|
924
Malibu Boats
MBUU
$579M
| $329K | 0.01% |
8,467
-3,708
| -30% | -$147K |
|
|
RDS.B
925
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $329K | 0.01% |
5,002
-686
| -12% | -$44.6K |
|
Similar funds
Joel Greenblatt's Q2 2019 Portfolio in Review
As of Q2 2019, Joel Greenblatt held 1,366 positions worth $6.27B, down 8.2% from $6.83B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Joel Greenblatt withdrew a net $642M in Q2 2019, closing 251 positions and reducing 489 holdings. Its most notable exit was Chemours, an estimated $49.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Intuit worth $46.3M.
- Joel Greenblatt's largest Q2 2019 buy was Intuit: 177,339 shares worth $46.3M.
- Joel Greenblatt added most to Cisco in Q2 2019, an estimated $38.8M increase.
- Joel Greenblatt's biggest Q2 2019 reduction was PayPal, cutting an estimated $61.2M.
- Joel Greenblatt fully exited Chemours in Q2 2019, selling an estimated $49.3M.
- Joel Greenblatt's ten largest holdings make up 10% of its $6.27B portfolio in Q2 2019.
- Joel Greenblatt opened 206 new positions and closed 251 in Q2 2019.
- Joel Greenblatt's portfolio value fell 8.2% quarter-over-quarter to $6.27B.
Based on Gotham Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.